MARK activation in human blood mononuclear cells in types 1 and 2 diabetes by V. V. Pushkarov, L. K. Sokolova, O. I. Kovzun, S. A. Cherviakova, T. S. Vatseba, V. M. Pushkarov, M. D. Tronko

Get full text

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease by M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova

Get full text

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients by M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchina, O. I. Kovzun, V. M. Pushkarev

Get full text

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease by V. V. Pushkarov, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchyna, O. I. Kovzun, V. M. Pushkarov, M. D. Tronko

Get full text

Untitled by M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova

Get full text

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment by L. K. Sokolova, V. M. Pushkarev, Yu. B. Belchina, V. V. Pushkarev, O. V. Furmanova, S. A. Cherviakova, O. I. Kovzun, M. D. Tronko

Get full text

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients by M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Y. B. Belchina, O. I. Kovzun, B. B. Guda, V. M. Pushkarev

Get full text